NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00630409 2017-03-10Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaUniversity of PittsburghPhase 2 Completed5 enrolled 2 charts